OTC Plan B outlook
This article was originally published in The Tan Sheet
Executive Summary
Nonprescription emergency contraception would contribute very little financially before July, CEO Bruce Downey indicated Jan. 6 at the Morgan Stanley Pharmaceutical CEOs Unplugged conference in New York. "I would expect sales to be up, but not necessarily this fiscal year," he said. Downey also noted the January PDUFA deadline for the dual-labeled OTC Plan B likely would be pushed back to Jan. 21 to accommodate the President's inauguration Jan. 20...